Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2482-2491

  Kim, Young Mi ^a   Jeon, Eun Su ^a   Kim, Mi Ra ^a   Jho, Sun Kug ^b   Ryu, Seok Woo ^b   Kim, Jae Ho ^a  

^a Pusan National University   (South Korea)

^b Busan Medical Center   (South Korea)

Author keywords

Smooth muscle actin; Angiotensin II; Differentiation; Mesenchymal stem cells; Smooth muscle cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; CALDESMON; CALPONIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN HEAVY CHAIN; POTASSIUM CHLORIDE; SMAD2 PROTEIN; SMAD7 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ADIPOSE TISSUE; ANGIOTENSIN II; ANIMALS; AUTOCRINE COMMUNICATION; CALCIUM; CELL DIFFERENTIATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 48449095398     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.016     Document Type: Article

References (46)

1. Ball S.G., Shuttleworth A.C., and Kielty C.M. Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36 (2004) 714-727
2. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36 (2004) 568-584
3. Berry C., Touyz R., Dominiczak A.F., Webb R.C., and Johns D.G. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281 (2001) H2337-H2365
4. Campbell S.E., and Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29 (1997) 1947-1958
5. Caplan A.I. Mesenchymal stem cells. J Orthop Res 9 (1991) 641-650
6. da Silva M.L., Chagastelles P.C., and Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119 (2006) 2204-2213
7. Davani S., Marandin A., Mersin N., Royer B., Kantelip B., Herve P., et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl. 1 (2003) II253-II258
8. Farrington-Rock C., Crofts N.J., Doherty M.J., Ashton B.A., Griffin-Jones C., and Canfield A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110 (2004) 2226-2232
9. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10 (1999) 3801-3813
10. Galmiche M.C., Koteliansky V.E., Briere J., Herve P., and Charbord P. Sromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82 (1993) 66-76
11. Gibbons G.H., Pratt R.E., and Dzau V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 90 (1992) 456-461
12. Gojo S., Gojo N., Takeda Y., Mori T., Abe H., Kyo S., et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288 (2003) 51-59
13. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol 10 (2000) 362-365
14. Hamaguchi A., Kim S., Izumi Y., Zhan Y., Yamanaka S., and Iwao H. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-β1 expression in vascular smooth muscle cells. Hypertension 34 (1999) 126-131
15. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., and Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond, Engl: 1979) 112 (2007) 417-428
16. Hirschi K.K., and Majesky M.W. Smooth muscle stem cells. Anat Rec Part A, Discov Mol Cell Evol Biol 276 (2004) 22-33
17. Hu B., Wu Z., and Phan S.H. Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression. Am J Respir Cell Mol Biol 29 (2003) 397-404
18. Jeon E.S., Moon H.J., Lee M.J., Song H.Y., Kim Y.M., Bae Y.C., et al. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-β-dependent mechanism. J Cell Sci 119 (2006) 4994-5005
19. Kinner B., Zaleskas J.M., and Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 278 (2002) 72-83
20. Kobayashi N., Yasu T., Ueba H., Sata M., Hashimoto S., Kuroki M., et al. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 32 (2004) 1238-1245
21. Kuriyama H., Kitamura K., Itoh T., and Inoue R. Physiological features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol Rev 78 (1998) 811-920
22. Liu C., Nath K.A., Katusic Z.S., and Caplice N.M. Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med 14 (2004) 288-293
23. Margariti A., Zeng L., and Xu Q. Stem cells, vascular smooth muscle cells and atherosclerosis. Histol Histopathol 21 (2006) 979-985
24. Minguell J.J., Erices A., and Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood, NJ) 226 (2001) 507-520
25. Ohtani K., Egashira K., Ihara Y., Nakano K., Funakoshi K., Zhao G., et al. Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension 48 (2006) 664-670
26. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
27. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
28. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
29. Qian H., Yang Y., Li J., Huang J., Dou K., and Yang G. The role of vascular stem cells in atherogenesis and post-angioplasty restenosis. Ageing Res Rev 6 (2007) 109-127
30. Roberts N., Jahangiri M., and Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 9 (2005) 583-591
31. Ross R., and Glomset J.A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295 (1976) 369-377
32. Schor A.M., Canfield A.E., Sutton A.B., Arciniegas E., and Allen T.D. Pericyte differentiation. Clin Orthop Relat Res 313 (1995) 81-91
33. Shen W.L., Gao P.J., Che Z.Q., Ji K.D., Yin M., Yan C., et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 339 (2006) 337-343
34. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., and Simmons P.J. Mesenchymal stem cells. Arch Med Res 34 (2003) 565-571
35. Sobue K., Hayashi K., and Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190 (1999) 105-118
36. Stouffer G.A., and Owens G.K. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 70 (1992) 820-828
37. Turla M.B., Thompson M.M., Corjay M.H., and Owens G.K. Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression. Circ Res 68 (1991) 288-299
38. Ueki N., Sobue K., Kanda K., Hada T., and Higashino K. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 84 (1987) 9049-9053
39. Wang D., Park J.S., Chu J.S., Krakowski A., Luo K., Chen D.J., et al. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor-β1 stimulation. J Biol Chem 279 (2004) 43725-43734
40. Wang W., Huang X.R., Canlas E., Oka K., Truong L.D., Deng C., et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 98 (2006) 1032-1039
41. Williams B. Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 87 (2001) 10C-17C
42. Yamada T., Kondo T., Numaguchi Y., Tsuzuki M., Matsubara T., Manabe I., et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol 27 (2007) 2363-2369
43. Yoo K.H., Thornhill B.A., Wolstenholme J.T., and Chevalier R.L. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 11 (1998) 715-722
44. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115 (2005) 326-338
45. Yoshida T., Hoofnagle M.H., and Owens G.K. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle α-actin. Circ Res 94 (2004) 1075-1082
46. Yurovsky V.V., Gerzanich V., Ivanova S., Dong Y., Tsymbalyuk O., and Simard J.M. Autocrine TGF-β1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo. Am J Hypertens 20 (2007) 950-956